From the 1st September 2020 onwards, the FISH service previously provided by the ROH Pathology Department will be transferred to the Molecular Pathology Diagnostic Service (MPDS) based at the QEHB.

All FISH tests previously performed in the ROH Pathology Laboratory have been validated again at the QEHB site following UKAS standards; these tests are awaiting submission for consideration within an extension to scope (ETS) application for accreditation. In the mean time, those tests will not fall under our scope of accredited tests but will be performed within our ISO accredited Laboratory.

Any external requests should be made to MPDS directly, as below. If you have any query, please feel free calling or/and emailing us.

Molecular Pathology

The Haematology Laboratory have moved to using a new Sickle Screening test kit in order to harmonise our testing method across all sites. 

The Specialist Coagulation Laboratory have started using a new Chromogenic FVIII assay, in addition to the one-stage FVIII assay. This is useful at diagnosis as some genetic variants for FVIII deficiency give discrepant results between one-stage and Chromogenic assays. It is also a useful assay if an inhibitor to FVIII is suspected.

Routine coagulation have started using a new back up semi-automated analyser so we can reliably check samples that fail on our fully automated system.  These failures are usually due to lipaemia or low fibrinogen. This will help us provide a more robust service to critically ill patients.

These tests are not currently accredited to ISO 15189 but will be added as part of our extension to scope in March 2021.

Download the vacutainer tube guide

QE Labs user survey results published

View here